{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:27:04Z","timestamp":1773480424893,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Royal Veterinary College research"},{"DOI":"10.13039\/501100000849","name":"NC3Rs studentship scheme","doi-asserted-by":"publisher","award":["NC\/L001500\/1"],"award-info":[{"award-number":["NC\/L001500\/1"]}],"id":[{"id":"10.13039\/501100000849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.neuropharm.2017.09.031","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T19:45:32Z","timestamp":1506109532000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-\u03b2 oligomers released from 7PA2 cells"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-6020","authenticated-orcid":false,"given":"Robin S.B.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Bate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.09.031_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-5-13","article-title":"Phospholipase A2 inhibitors protect against prion and A\u03b2 mediated synapse degeneration","volume":"5","author":"Bate","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib2","doi-asserted-by":"crossref","first-page":"41443","DOI":"10.1074\/jbc.M110.141390","article-title":"The transcriptionally active Amyloid Precursor Protein (APP) Intracellular domain is preferentially produced from the 695 isoform of APP in a \u03b2-secretase-dependent pathway","volume":"285","author":"Belyaev","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A[beta] oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-4159.2003.01701.x","article-title":"Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain","volume":"85","author":"Bosetti","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","article-title":"Seizure control by ketogenic diet-associated medium chain fatty acids","volume":"69","author":"Chang","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00005072-200606000-00007","article-title":"Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment","volume":"65","author":"Counts","year":"2006","journal-title":"J.\u00a0Neuropath Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/bbrc.1993.2474","article-title":"Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein","volume":"197","author":"Emmerling","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib9","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bcp.2005.02.012","article-title":"Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives","volume":"69","author":"Eyal","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib10","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"\u03b2\u2212amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib11","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.39.3.355","article-title":"Synaptic loss in Alzheimer's disease and other dementias","volume":"39","author":"Hamos","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720506775697098","article-title":"Has the amyloid cascade hypothesis for Alzheimer's disease been proved?","volume":"3","author":"Hardy","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(94)00422-2","article-title":"Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease","volume":"64","author":"Heinonen","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2007.06.116","article-title":"Defective cholesterol traffic and neuronal differentiation in neural stem cells of Niemann-Pick type C disease improved by valproic acid, a histone deacetylase inhibitor","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib16","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","article-title":"Amyloid-\u03b2 protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization","volume":"28","author":"Klyubin","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib17","doi-asserted-by":"crossref","first-page":"24765","DOI":"10.1074\/jbc.M111.329763","article-title":"Conformational differences between two amyloid \u03b2 oligomers of similar size and dissimilar toxicity","volume":"287","author":"Ladiwala","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib18","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from A\u03b21-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0304-4157(00)00007-1","article-title":"Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid\/cholesterol membrane domains (rafts)","volume":"1508","author":"London","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib20","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awq065","article-title":"The presence of sodium dodecyl sulphate-stable A\u03b2 dimers is strongly associated with Alzheimer-type dementia","volume":"133","author":"Mc Donald","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12031-011-9644-x","article-title":"Effect of sodium valproate administration on brain neprilysin expression and memory in rats","volume":"46","author":"Nalivaeva","year":"2012","journal-title":"J.\u00a0Mol. Neurosci. MN"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1083\/jcb.153.3.529","article-title":"Rapid cycling of lipid raft markers between the cell surface and Golgi complex","volume":"153","author":"Nichols","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib23","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib24","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1074\/jbc.270.16.9564","article-title":"Aggregation of secreted amyloid \u03b2-protein into sodium dodecyl sulfate-stable oligomers in cell culture","volume":"270","author":"Podlisny","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib25","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib26","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits A\u03b2 production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib28","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1194\/jlr.D007336","article-title":"A\u00a0simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells","volume":"51","author":"Robinet","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib30","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-\u03b2 protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib32","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib34","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1042\/BCJ20160147","article-title":"Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions","volume":"473","author":"Toh","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib35","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib36","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1021\/bi001048s","article-title":"The oligomerization of amyloid\u2212\u03b2-protein begins intracellularly in cells derived from human brain","volume":"39","author":"Walsh","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in\u00a0vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","article-title":"The role of cell-derived oligomers of A\u03b2 in Alzheimer's disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2017.09.031_bib40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.neuropharm.2015.06.013","article-title":"An in\u00a0vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling","volume":"101","author":"Williams","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.09.031_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.1698-16.2016","article-title":"Large Soluble Oligomers of amyloid \u03b2-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate","volume":"37","author":"Yang","year":"2017","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817304483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T06:57:27Z","timestamp":1535353047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817304483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"alternative-id":["S0028390817304483"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-\u03b2 oligomers released from 7PA2 cells","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}